Silence or regulate mRNA, microRNA or long non-coding RNA. FANA technology provides superior alternatives to CRISPR, siRNA and shRNA approaches.
Key Attributes: FANA Antisense Oligonucleotides (FANA – ASOs)
FANAs have high intracellular stability as well as high binding affinity to the target RNA forming very stable heteroduplex structures. Unlike conventional technologies, FANAs have high fidelity for the RNA target and highly reduced off target effects (no RISC associated off target effects). These attributes represent a more potent, efficient, and cost effective solution in the RNA silencing and regulation space.
FANA Antisense Oligonucleotide (FANA – ASO) technology provides is a superior alternative to siRNA-mediated gene knockdown.
FANA Antisense Oligonucleotide (FANA – ASO) technology provides an alternative to shRNA-mediated gene knockdown.
FANA Antisense Oligonucleotide (FANA – ASO) technology provides an alternative to conventional oligo approaches.
FANA Antisense Oligonucleotide (FANA – ASO) technology provides an alternative to CRISPR sgRNA Libraries.
FANA Antisense Oligonucleotide (FANA – ASO) technology provides alternatives to genome editing approaches.
FANA Antisense Oligonucleotide (FANA – ASO) technology provides an alternative to CRISPR/Cas9 Genome Editing.
Genetic Engineering Services
DNA Synthesis and Probe Development Services
AUM BioTech, LLC has not received any reviews.
AUM BioTech, LLC has not received any endorsements.